PETER C FARRELL, a director at $RMD, sold 2,000 shares of the company on 12-03-2025 for an estimated $502,940. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.8% of their shares of this class of stock. Following this trade, they now own 68,773 shares of this class of $RMD stock.
$RMD Insider Trading Activity
$RMD insiders have traded $RMD stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $RMD stock by insiders over the last 6 months:
- MICHAEL J. FARRELL (Chairman and CEO) has made 0 purchases and 6 sales selling 48,056 shares for an estimated $12,800,059.
- BRETT SANDERCOCK (Chief Financial Officer) has made 0 purchases and 6 sales selling 16,883 shares for an estimated $4,465,762.
- PETER C FARRELL has made 0 purchases and 3 sales selling 4,945 shares for an estimated $1,248,478.
- JOHN HERNANDEZ sold 2,575 shares for an estimated $739,289
- WITTE JAN DE has made 0 purchases and 2 sales selling 2,542 shares for an estimated $645,896.
- MICHAEL J RIDER (Global General Counsel) has made 0 purchases and 3 sales selling 166 shares for an estimated $43,264.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RMD Hedge Fund Activity
We have seen 461 institutional investors add shares of $RMD stock to their portfolio, and 457 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 773,400 shares (+74.4%) to their portfolio in Q3 2025, for an estimated $211,702,782
- NORGES BANK added 669,170 shares (+129.0%) to their portfolio in Q2 2025, for an estimated $172,645,860
- FMR LLC added 535,507 shares (+155.3%) to their portfolio in Q3 2025, for an estimated $146,584,331
- BANK OF NEW YORK MELLON CORP removed 492,643 shares (-9.8%) from their portfolio in Q3 2025, for an estimated $134,851,168
- PRICE T ROWE ASSOCIATES INC /MD/ added 429,050 shares (+125.0%) to their portfolio in Q3 2025, for an estimated $117,443,856
- MORGAN STANLEY removed 347,095 shares (-13.0%) from their portfolio in Q3 2025, for an estimated $95,010,314
- UBS GROUP AG added 339,774 shares (+63.7%) to their portfolio in Q3 2025, for an estimated $93,006,337
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RMD Revenue
$RMD had revenues of $1.3B in Q1 2026. This is an increase of 9.07% from the same period in the prior year.
You can track RMD financials on Quiver Quantitative's RMD stock page.
$RMD Analyst Ratings
Wall Street analysts have issued reports on $RMD in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 11/03/2025
- Mizuho issued a "Outperform" rating on 10/31/2025
- RBC Capital issued a "Outperform" rating on 10/31/2025
- Morgan Stanley issued a "Overweight" rating on 10/21/2025
- Citigroup issued a "Buy" rating on 09/18/2025
- UBS issued a "Buy" rating on 08/01/2025
To track analyst ratings and price targets for $RMD, check out Quiver Quantitative's $RMD forecast page.
$RMD Price Targets
Multiple analysts have issued price targets for $RMD recently. We have seen 10 analysts offer price targets for $RMD in the last 6 months, with a median target of $300.0.
Here are some recent targets:
- Joe Vruwink from Baird set a target price of $300.0 on 11/03/2025
- Anthony Petrone from Mizuho set a target price of $300.0 on 10/31/2025
- Brett Fishbin from Keybanc set a target price of $299.0 on 10/31/2025
- Craig Wong-Pan from RBC Capital set a target price of $303.0 on 10/31/2025
- Sean Laaman from Morgan Stanley set a target price of $304.0 on 10/21/2025
- Nathan Treybeck from Wells Fargo set a target price of $280.0 on 10/13/2025
- Laura Sutcliffe from Citigroup set a target price of $330.0 on 09/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
